STAAB THOMAS R II — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

STAAB THOMAS R II has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

STAAB THOMAS R II

Thomas R. Staab II is the Chief Financial Officer of Lensar, Inc., a medical device company focused on cataract laser systems, as indicated by the most recent SEC insider filing dated January 13, 2026. The filing lists Staab in the CFO role with no reported stock purchases or sales. Lensar develops and markets the LENSAR Laser System designed to aid imaging, planning, and precision in cataract surgery.

RoleInsider
Notability40/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-13TENXTENAX THERAPEUTICS, INC.A — Grant or award10.0K$0.00
2026-05-08LNSRLENSAR, Inc.F — Tax withholding / forfeiture1.4K$5.38$7K
2026-03-19LNSRLENSAR, Inc.M — Option exercise5.5K$2.65$15K
2026-02-20LNSRLENSAR, Inc.F — Tax withholding / forfeiture1.1K$11.32$12K
2026-01-13LNSRLENSAR, Inc.F — Tax withholding / forfeiture1.8K$11.57$21K

Companies — Last 90 Days

Frequently Asked Questions

Who is STAAB THOMAS R II?

Thomas R. Staab II is the Chief Financial Officer of Lensar, Inc., a medical device company focused on cataract laser systems, as indicated by the most recent SEC insider filing dated January 13, 2026. The filing lists Staab in the CFO role with no reported stock purchases or sales. Lensar develops and markets the LENSAR Laser System designed to aid imaging, planning, and preci…

How many SEC Form 4 filings has STAAB THOMAS R II submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of STAAB THOMAS R II's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live STAAB THOMAS R II profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.